Cell Counting Kit-8 (CCK-8): Sensitive WST-8 Cell Viability and Proliferation Assay

Executive Summary: The Cell Counting Kit-8 (CCK-8) utilizes water-soluble tetrazolium salt WST-8 for sensitive detection of cell viability, proliferation, and cytotoxicity [product]. The assay quantitates mitochondrial dehydrogenase activity in live cells, with results directly correlating to cell number (Wang et al., 2025). CCK-8 offers improved sensitivity and workflow efficiency over legacy MTT, XTT, and MTS assays [internal]. The water solubility of WST-8 formazan eliminates organic solvent extraction, streamlining the protocol. CCK-8 is broadly validated in cancer, stem cell, and metabolic research. Limitations include sensitivity to mitochondrial metabolism and potential interference from test compounds.

Biological Rationale

Accurate quantification of live cells is essential for evaluating proliferation, viability, and cytotoxicity in biomedical research. Cellular metabolic activity, primarily through mitochondrial dehydrogenases, reflects cell health and number (Wang et al., 2025). WST-8-based assays measure the reduction of a tetrazolium salt to a colored formazan product by active cells. This reaction is proportional to the number of viable, metabolically active cells. CCK-8 is routinely used in oncology, regenerative medicine, and toxicity testing due to its specificity and convenience. Recent studies confirm its utility in mesenchymal stem cell proliferation analysis, including rare disease models such as congenital tibial pseudarthrosis (Wang et al., 2025).

Mechanism of Action of Cell Counting Kit-8 (CCK-8)

The CCK-8 assay employs WST-8, a water-soluble tetrazolium salt. In viable cells, mitochondrial dehydrogenases reduce WST-8 to a soluble orange formazan dye. The amount of formazan produced is directly proportional to the number of living cells and is measured spectrophotometrically at 450 nm. Unlike MTT, which forms insoluble formazan crystals requiring solubilization, CCK-8’s formazan is water-soluble, enabling direct, non-destructive quantification [product]. The assay is non-radioactive and does not require cell washing or organic extraction steps. It is compatible with standard 96- and 384-well microplates, supporting both endpoint and kinetic measurements [internal].

Evidence & Benchmarks

• CCK-8 detects cell proliferation with higher sensitivity than MTT, XTT, or MTS, with linearity from 500 to 100,000 cells per well under standard culture conditions (Wang et al., 2025, DOI).
• In congenital tibial pseudarthrosis research, CCK-8 reliably quantified differences in mesenchymal stem cell (MSC) proliferation and response to pamidronate, correlating with osteogenic differentiation outcomes (Wang et al., 2025, DOI).
• CCK-8’s water-soluble formazan eliminates the need for organic solvents, reducing hands-on time and experimental variability (ApexBio, product page).
• Interference from high-reducing agents or colored test compounds can affect readouts, highlighting the importance of proper controls (ApexBio, product page).
• Compared to legacy assays, CCK-8 is more compatible with high-throughput and automated workflows, increasing reproducibility (Biotin-Azide, internal article).

Applications, Limits & Misconceptions

CCK-8 is widely used to quantify cell proliferation, viability, and cytotoxicity in vitro. Its applications span cancer cell line screening, drug sensitivity testing, stem cell biology, and neurodegenerative disease models. For instance, it has been pivotal in evaluating the proliferation and differentiation of MSCs in orthopedic research (Wang et al., 2025).

This article extends prior coverage on superior sensitivity of CCK-8 by detailing clinical translational applications and benchmarking against new disease models. For further workflow optimization, see our in-depth troubleshooting and protocol article, which this review updates with recent comparative studies.

Common Pitfalls or Misconceptions

• Non-viable cells do not produce formazan: CCK-8 only measures metabolically active, viable cells. Dead or apoptotic cells are not detected.
• Metabolic inhibitors may confound results: Agents that suppress mitochondrial dehydrogenase activity can yield false low readings, independent of cell number.
• Colored compounds or high reducing agents interfere: Test substances with absorbance at 450 nm or with reducing capacity may affect results; appropriate controls are mandatory.
• Not suitable for non-adherent cell types without optimization: Suspension cultures may require protocol adjustments to avoid uneven dye distribution.
• Cannot distinguish between cell cycle phases: The assay quantifies total viable cells only, not their proliferative state or differentiation status.

Workflow Integration & Parameters

To perform the CCK-8 assay, seed cells in a 96- or 384-well plate (typical range: 500–10,000 cells/well). After treatment, add 10 μL of CCK-8 solution per 100 μL of medium. Incubate at 37°C in 5% CO₂ for 1–4 h. Measure absorbance at 450 nm using a microplate reader. Results can be directly correlated to cell number via standard curves. The assay is compatible with most culture media and does not require cell washing or lysis. For high-throughput studies, CCK-8 supports automated liquid handling. If using test agents with potential absorbance overlap or redox activity, always include vehicle and background controls [internal protocol contrasts]. For advanced applications—such as oxidative stress or mitochondrial function assessment—refer to this article on oxidative stress applications, which this guide extends by contextualizing CCK-8 performance in disease-relevant models.

Conclusion & Outlook

The Cell Counting Kit-8 (CCK-8) provides a robust, reproducible, and sensitive platform for quantifying cell viability and proliferation in vitro. Its WST-8 chemistry and workflow simplicity make it superior to traditional formazan-based assays, as evidenced in diverse research areas from cancer biology to rare orthopedic disease. Users should be aware of assay-specific limitations, particularly interference from metabolic modulators or colored compounds. Overall, CCK-8 remains a critical tool for high-throughput cell-based screening and translational research. For detailed product specifications and ordering, visit the Cell Counting Kit-8 (CCK-8) product page.